Page last updated: 2024-11-04

gatifloxacin and Legionellosis

gatifloxacin has been researched along with Legionellosis in 2 studies

Gatifloxacin: A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
gatifloxacin : A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.

Legionellosis: Infections with bacteria of the genus LEGIONELLA.

Research Excerpts

ExcerptRelevanceReference
" Azithromycin, clarithromycin, ciprofloxacin, and gemifloxacin were also effective for treating legionellosis."3.76[Antimicrobial susceptibility patterns of Legionella isolates in the environment and in patients]. ( Chang, CL; Choi, GE; Kang, JE; Kim, JM; Kim, KH; Lee, EY; Tateda, K; Yamaguchi, K, 2010)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choi, GE1
Kang, JE1
Lee, EY1
Chang, CL1
Tateda, K1
Yamaguchi, K1
Kim, KH1
Kim, JM1
Croco, MA1
Biedenbach, DJ1
Pfaller, MA1
Doern, GV1
Jones, RN1

Other Studies

2 other studies available for gatifloxacin and Legionellosis

ArticleYear
[Antimicrobial susceptibility patterns of Legionella isolates in the environment and in patients].
    The Korean journal of laboratory medicine, 2010, Volume: 30, Issue:1

    Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Clindamycin; Drug Resistance, Ba

2010
In-vitro activities of gatifloxacin, sparfloxacin and trovafloxacin against 103 strains of Legionella spp.
    The Journal of antimicrobial chemotherapy, 1998, Volume: 42, Issue:5

    Topics: Anti-Infective Agents; Fluoroquinolones; Gatifloxacin; Humans; Legionella; Legionella pneumophila; L

1998